The stock of AdaptHealth Corp (AHCO) has gone up by 4.00% for the week, with a 1.45% rise in the past month and a -15.96% drop in the past quarter. The volatility ratio for the week is 4.67%, and the volatility levels for the past 30 days are 3.91% for AHCO.. The simple moving average for the past 20 days is 2.93% for AHCO’s stock, with a -6.59% simple moving average for the past 200 days.
Is It Worth Investing in AdaptHealth Corp (NASDAQ: AHCO) Right Now?
The price-to-earnings ratio for AdaptHealth Corp (NASDAQ: AHCO) is above average at 16.06x, Company’s 36-month beta value is 1.64.Analysts have differing opinions on the stock, with 5 analysts rating it as a “buy,” 1 as “overweight,” 2 as “hold,” and 0 as “sell.”
The average price point forecasted by analysts for AdaptHealth Corp (AHCO) is N/A, which is -$1499987.12 below the current market price. The public float for AHCO is 86.66M, and currently, short sellers hold a 10.00% ratio of that floaft. The average trading volume of AHCO on July 01, 2025 was 1.50M shares.
AHCO) stock’s latest price update
The stock of AdaptHealth Corp (NASDAQ: AHCO) has decreased by -3.39 when compared to last closing price of 9.43. However, the company has seen a gain of 4.00% in its stock price over the last five trading days. businesswire.com reported 2025-06-30 that CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced that it has closed on the previously disclosed disposition of certain infusion assets in its Wellness at Home segment to a third party. The transaction was completed earlier this month. “The disposition of certain infusion asset.
Analysts’ Opinion of AHCO
Many brokerage firms have already submitted their reports for AHCO stocks, with Jefferies repeating the rating for AHCO by listing it as a “Hold.” The predicted price for AHCO in the upcoming period, according to Jefferies is $8 based on the research report published on January 08, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see AHCO reach a price target of $6.50, previously predicting the price at $9.50. The rating they have provided for AHCO stocks is “Underperform” according to the report published on November 08th, 2023.
Stifel gave a rating of “Hold” to AHCO, setting the target price at $11 in the report published on May 10th of the previous year.
AHCO Trading at 4.42% from the 50-Day Moving Average
After a stumble in the market that brought AHCO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.45% of loss for the given period.
Volatility was left at 3.91%, however, over the last 30 days, the volatility rate increased by 4.67%, as shares surge +3.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +16.56% upper at present.
During the last 5 trading sessions, AHCO rose by +3.65%, which changed the moving average for the period of 200-days by -19.07% in comparison to the 20-day moving average, which settled at $8.85. In addition, AdaptHealth Corp saw -7.61% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AHCO starting from Rietkerk Shaw, who proposed sale 32,500 shares at the price of $9.70 back on Dec 19 ’24. After this action, Rietkerk Shaw now owns N/A shares of AdaptHealth Corp, valued at $315,250 using the latest closing price.
Clemens Jason A, the Chief Financial Officer of AdaptHealth Corp, sale 35,000 shares at $9.35 during a trade that took place back on Dec 10 ’24, which means that Clemens Jason A is holding 420,719 shares at $327,250 based on the most recent closing price.
Stock Fundamentals for AHCO
Current profitability levels for the company are sitting at:
- 0.08 for the present operating margin
- 0.16 for the gross margin
The net margin for AdaptHealth Corp stands at 0.03. The total capital return value is set at 0.06. Equity return is now at value 5.12, with 1.73 for asset returns.
Based on AdaptHealth Corp (AHCO), the company’s capital structure generated 0.57 points at debt to capital in total, while cash flow to debt ratio is standing at 0.28. The debt to equity ratio resting at 1.34. The interest coverage ratio of the stock is 1.98.
Currently, EBITDA for the company is 303.37 million with net debt to EBITDA at 3.28. When we switch over and look at the enterprise to sales, we see a ratio of 1.08. The receivables turnover for the company is 7.29for trailing twelve months and the total asset turnover is 0.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.29.
Conclusion
In a nutshell, AdaptHealth Corp (AHCO) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
